Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer

Alissa R Link, Marilie D Gammon, Judith S Jacobson, Page Abrahamson, Patrick T Bradshaw, Mary Beth Terry, Susan Teitelbaum, Alfred Neugut, Heather Greenlee, Alissa R Link, Marilie D Gammon, Judith S Jacobson, Page Abrahamson, Patrick T Bradshaw, Mary Beth Terry, Susan Teitelbaum, Alfred Neugut, Heather Greenlee

Abstract

Purpose. We examine factors associated with self-care, use of practitioner-based complementary and alternative medicine (CAM), and their timing in a cohort of women with breast cancer. Methods. Study participants were women with breast cancer who participated in the Long Island Breast Cancer Study Project. Self-care is defined as the use of multivitamins, single vitamins, botanicals, other dietary supplements, mind-body practices, special diets, support groups, and prayer. Within each modality, study participants were categorized as continuous users (before and after diagnosis), starters (only after diagnosis), quitters (only before diagnosis), or never users. Multivariable logistic regression was used for the main analyses. Results. Of 764 women who provided complete data, 513 (67.2%) initiated a new form of self-care following breast cancer diagnosis. The most popular modalities were those that are ingestible, and they were commonly used in combination. The strongest predictor of continuous use of one type of self-care was continuous use of other types of self-care. Healthy behaviors, including high fruit/vegetable intake and exercise, were more strongly associated with continuously using self-care than starting self-care after diagnosis. Conclusions. Breast cancer diagnosis was associated with subsequent behavioral changes, and the majority of women undertook new forms of self-care after diagnosis. Few women discontinued use of modalities they used prior to diagnosis.

References

    1. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports. 2009;(12):1–23.
    1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. Journal of the American Medical Association. 1998;280(18):1569–1575.
    1. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Advance Data. 2004;(343):1–19.
    1. Saydah SH, Eberhardt MS. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. Journal of Alternative and Complementary Medicine. 2006;12(8):805–812.
    1. Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. Journal of Alternative and Complementary Medicine. 2002;8(4):477–485.
    1. Fasching PA, Thiel F, Nicolaisen-Murmann K, et al. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Supportive Care in Cancer. 2007;15(11):1277–1284.
    1. Nahleh Z, Tabbara IA. Complementary and alternative medicine in breast cancer patients. Palliative & Supportive Care. 2003;1(3):267–273.
    1. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. Journal of the National Cancer Institute. 2000;92(1):42–47.
    1. Greenlee H, Kwan ML, Ergas IJ, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Research and Treatment. 2009;117(3):653–665.
    1. Wanchai A, Armer JM, Stewart BR. Complementary and alternative medicine use among women with breast cancer: a systematic review. Clinical Journal of Oncology Nursing. 2010;14(4):E45–E55.
    1. Henderson JW, Donatelle RJ. The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-Oncology. 2003;12(1):59–67.
    1. Gammon MD, Neugut AI, Santella RM, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Research and Treatment. 2002;74(3):235–254.
    1. Fink BN, Gaudet MM, Britton JA, et al. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Research and Treatment. 2006;98(2):199–208.
    1. Greenlee H, Gammon MD, Abrahamson PE, et al. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer. 2009;115(14):3271–3282.
    1. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise and reduced risk of breast cancer in young women. Journal of the National Cancer Institute. 1994;86(18):1403–1408.
    1. Block G, Hartman AM, Dresser CM. A data-based approach to diet questionnaire design and testing. American Journal of Epidemiology. 1986;124(3):453–469.
    1. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd edition. Wiley-Interscience; 2000.
    1. Perlman A, Lontok O, Huhmann M, et al. Prevalence and correlates of postdiagnosis initiation of complementary and alternative medicine among patients at a comprehensive cancer center. Journal of Oncology Practice. 2012
    1. Astin JA, Reilly C, Perkins C, Child WL. Breast cancer patients’ perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. Journal of the Society for Integrative Oncology. 2006;4(4):157–169.
    1. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. The New England Journal of Medicine. 1999;340(22):1733–1739.
    1. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology. 2000;18(13):2505–2514.
    1. Astin JA, Marie A, Pelletier KR, Hansen E, Haskell WL. A review of the incorporation of complementary and alternative medicine by mainstream physicians. Archives of Internal Medicine. 1998;158(21):2303–2310.
    1. Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, Buiatti E. The use of complementary therapies by breast cancer patients attending conventional treatment. European Journal of Cancer. 1998;34(3):324–328.
    1. Newman V, Rock CL, Faerber S, Flatt SW, Wright FA, Pierce JP. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. Journal of the American Dietetic Association. 1998;98(3):285–292.
    1. Mansky PJ, Wallerstedt DB. Complementary medicine in palliative care and cancer symptom management. Cancer Journal. 2006;12(5):425–431.
    1. Thomas J, Beinhorn C, Norton D, Richardson M, Sumler S-S, Frenkel M. Managing radiation therapy side effects with complementary medicine. Journal of the Society for Integrative Oncology. 2010;8(2):65–80.
    1. Lengacher CA, Bennett MP, Kip KE, Gonzalez L, Jacobsen P, Cox CE. Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. Oncology Nursing Forum. 2006;33(1):97–104.
    1. Lo-Fo-Wong DNN, Ranchor AV, de Haes HCJM, Sprangers MAG, Henselmans I. Complementary and alternative medicine use of women with breast cancer: self-help CAM attracts other women than guided CAM therapies. Patient Education and Counseling. 2012;89(3):529–536.
    1. Jacobson JS, Workman SB, Kronenberg F. Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature. Journal of Clinical Oncology. 2000;18(3):668–683.
    1. Ell K, Nishimoto R, Morvay T, Mantell J, Hamovitch M. A longitudinal analysis of psychological adaptation among survivors of cancer. Cancer. 1989;63(2):406–413.
    1. Dow KH, Ferrell BR, Haberman MR, Eaton L. The meaning of quality of life in cancer survivorship. Oncology Nursing Forum. 1999;26(3):519–528.
    1. Gerits P, De Brabander B. Psychosocial predictors of psychological, neurochemical and immunological symptoms of acute stress among breast cancer patients. Psychiatry Research. 1999;85(1):95–103.
    1. Tjemsland L, Søreide JA, Matre R, Malt UF. Pre-operative psychological variates predict immunological status in patients with operable breast cancer. Psycho-Oncology. 1997;6(4):311–320.
    1. Deng G, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. Journal of the Society for Integrative Oncology. 2009;7(3):85–120.
    1. Cassileth BR, Deng GE, Gomez JE, Johnstone PAS, Kumar N, Vickers AJ. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines. Chest. 2007;132(3, supplement):340S–354S.
    1. Deng GE, Cassileth BR, Cohen L, et al. Integrative oncology practice guidelines. Journal of the Society for Integrative Oncology. 2007;5(2):65–84.

Source: PubMed

3
Suscribir